Follow the BB Biotech AG stock price and the full insider trade history of the company, a listed issuer based in Switzerland. Shares trade on the CH market, under the oversight of SIX SER. Operating in the Health Care sector, BB Biotech AG has logged 7 public disclosures. Market capitalisation: €2.9bn. The latest transaction was reported on 5 March 2025 (Purchase). The full history is openly available.
7
Insider Decl.
n/a
Thresholds
€1m
7 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BB Biotech AG Strong Buy (bullish), based on 2 analysts. Average price target: CHF 69.00.
30Σ signal
Buys €1mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 33 of 29,024 companies
94.1
score / 100
Value
91
Quality
98
FCF yld11%
Earn yld20%
EV/EBITDA·
ROE35%
Gross mgn·
Net mgn98%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2025
Declarations7 total
●
Anonymous (Non-executive member of the board of directors)
Non-executive member of the board of directors·Executives·